NASDAQ:NH

NantHealth - NH Stock Forecast, Price & News

$0.25

-0.01 (-3.79%)

(As of 12/8/2022 12:00 AM ET)

Add

Compare

Today's Range: $0.25
▼
$0.28
50-Day Range: $0.24
▼
$0.39
52-Week Range: $0.17
▼
$1.15

Volume: 6,769 shs
Average Volume: 89,680 shs
Market Capitalization: $29.33 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About NantHealth (NASDAQ:NH) Stock

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Stock News Headlines

December 8, 2022 | americanbankingnews.com

StockNews.com Initiates Coverage on NantHealth (NASDAQ:NH)

December 1, 2022 | americanbankingnews.com

NantHealth (NASDAQ:NH) Earns Hold Rating from Analysts at StockNews.com

November 9, 2022 | finance.yahoo.com

NantHealth Third Quarter 2022 Earnings: US$0.12 loss per share (vs US$0.094 loss in 3Q 2021)

November 4, 2022 | finance.yahoo.com

NantHealth Reports 2022 Third Quarter Financial Results

November 1, 2022 | finance.yahoo.com

NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3

October 16, 2022 | fool.com

NantHealth, Inc. (NASDAQ: NH)

October 11, 2022 | finance.yahoo.com

WellStack Expands Executive Team with Chief Revenue Officer Christopher Rogowski - Yahoo Finance

October 5, 2022 | benzinga.com

11 Health Care Stocks Moving In Wednesday's Pre-Market Session - Applied DNA Sciences (NASDAQ:APDN), Aven - Benzinga

September 27, 2022 | globenewswire.com

Global Respiratory Care Devices Market expanding at a high-value CAGR of 8.3% by the end of 2032 - GlobeNewswire

September 9, 2022 | uk.investing.com

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday By Benzinga - Investing.com UK

September 5, 2022 | bizjournals.com

Billionaire's Morrisville firm tries to forestall stock delisting from the Nasdaq

August 24, 2022 | businesswire.com

NantHealth's Eviti Platform Once More Earns Full URAC Accreditation Through 2025 - Business Wire

August 24, 2022 | finance.yahoo.com

NantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025

August 12, 2022 | finance.yahoo.com

Sarah Chavarria Named President of Delta Dental of California and Affiliates - Yahoo Finance

August 5, 2022 | fool.com

NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript - The Motley Fool

August 5, 2022 | finance.yahoo.com

NantHealth, Inc. (NH) Q2 2022 Earnings Call Transcript

August 4, 2022 | businesswire.com

NantHealth Reports 2022 Second Quarter Financial Results - Business Wire

August 4, 2022 | finance.yahoo.com

NantHealth Reports 2022 Second Quarter Financial Results

August 1, 2022 | finance.yahoo.com

NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Yahoo Finance

August 1, 2022 | businesswire.com

NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4 - Business Wire

August 1, 2022 | finance.yahoo.com

NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4

July 12, 2022 | streetinsider.com

Xealth Expands Leadership Team with Appointments of Joe Sedlak, RN, and Laurance Stuntz - StreetInsider.com

July 8, 2022 | finance.yahoo.com

NantHealth (NASDAQ:NH) investors are sitting on a loss of 90% if they invested five years ago

June 8, 2022 | finance.yahoo.com

The OpenNMS Group Launches Horizon 30, the Latest Major Release of its Open Source Network Monitoring Solution, Featuring Enhanced Capabilities Designed for the Enterprise

May 17, 2022 | finance.yahoo.com

NantHealth NaviNet Open Wins "Healthcare Insurance Innovation Award" in 2022 MedTech Breakthrough Awards Program - Yahoo Finance

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NantHealth and its competitors with MarketBeat's FREE daily newsletter.

NH Company Calendar

Last Earnings: 11/03/2022
Today: 12/08/2022
Fiscal Year End: 12/31/2022
Next Earnings (Estimated): 2/23/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Data processing & preparation
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:NH
Previous Symbol: NYSE:NH
CUSIP: N/A
CIK: 1566469
Web: www.nanthealth.com
Phone: (310) 883-1300
Fax: N/A
Employees: 326
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.51)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-58,260,000.00
Net Margins: -89.76%
Pretax Margin: -89.67%
Return on Equity: N/A
Return on Assets: -30.69%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.36
Quick Ratio: 0.36

Sales & Book Value

Annual Sales: $62.65 million
Price / Sales: 0.47
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($1.40) per share
Price / Book: -0.18

Miscellaneous

Outstanding Shares: 115,550,000
Free Float: 44,718,000
Market Cap: $29.33 million
Optionable: Optionable
Beta: 2.00

Key Executives

Dr. Patrick Soon-Shiong FACS (Age 69)
FRCS (C), M.Sc., Founder, Chairman & CEO

Mr. Bob Petrou (Age 50)
Chief Financial Officer
Comp: $556.27k

Mr. Ronald Allen Louks (Age 57)
Chief Operating Officer
Comp: $837.05k

Mr. Mark Mozley
Sr. VP of Corp. Devel.

Mr. Jerry Magin
Sr. VP of Global Sales & Marketing

Mr. Arlyn R. Small Jr.
Sr. VP of HR

Mr. Keith Krebs
Sr. VP of Client Services

Mr. Chris House
Sr. VP of Product Management & Devel.

Dr. Tiffany Avery
Chief Medical Officer

Mr. Neil Carpenter
Sr. VP of Strategy & Chief Strategy Officer

Key Competitors

View All Competitors

NH Stock - Frequently Asked Questions

Should I buy or sell NantHealth stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NH shares.
View NH analyst ratings or view top-rated stocks.
How have NH shares performed in 2022?: NantHealth's stock was trading at $1.0550 on January 1st, 2022. Since then, NH shares have decreased by 74.7% and is now trading at $0.2670.
View the best growth stocks for 2022 here.
Are investors shorting NantHealth?: NantHealth saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 328,900 shares, an increase of 27.8% from the October 31st total of 257,400 shares. Based on an average daily volume of 73,400 shares, the short-interest ratio is presently 4.5 days. Currently, 0.7% of the company's stock are sold short.
View NantHealth's Short Interest.
When is NantHealth's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our NH earnings forecast.
How were NantHealth's earnings last quarter?: NantHealth, Inc. (NASDAQ:NH) posted its quarterly earnings results on Thursday, November, 3rd. The company reported ($0.13) earnings per share for the quarter. The company earned $16.63 million during the quarter.
What is Patrick Soon-Shiong's approval rating as NantHealth's CEO?: 82 employees have rated NantHealth Chief Executive Officer Patrick Soon-Shiong on Glassdoor.com. Patrick Soon-Shiong has an approval rating of 49% among the company's employees. This puts Patrick Soon-Shiong in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of NantHealth own?: Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Inovio Pharmaceuticals (INO), Micron Technology (MU), NantKwest (NK), AbbVie (ABBV), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH) and Netflix (NFLX).
When did NantHealth IPO?: (NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company served as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.
What is NantHealth's stock symbol?: NantHealth trades on the NASDAQ under the ticker symbol "NH."
How do I buy shares of NantHealth?: Shares of NH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is NantHealth's stock price today?: One share of NH stock can currently be purchased for approximately $0.27.
How much money does NantHealth make?: NantHealth (NASDAQ:NH) has a market capitalization of $30.85 million and generates $62.65 million in revenue each year. The company earns $-58,260,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis.
How many employees does NantHealth have?: The company employs 326 workers across the globe.
How can I contact NantHealth?: NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The official website for the company is www.nanthealth.com. The company can be reached via phone at (310) 883-1300 or via email at ir@nanthealth.com.

This page (NASDAQ:NH) was last updated on 12/8/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial